Ingevity (NGVT)
(Delayed Data from NYSE)
$38.44 USD
+1.94 (5.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $38.46 +0.02 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 0.75 |
EPS Last Quarter | 1.01 |
Last EPS Surprise | -3.81% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.63 |
Next Year | 3.80 |
EPS (TTM) | 2.95 |
P/E (F1) | 14.62 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 375.80M | 319.40M | 1.41B | 1.46B |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 375.80M | 319.40M | 1.43B | 1.49B |
Low Estimate | 375.80M | 319.40M | 1.40B | 1.43B |
Year ago Sales | 446.00M | 371.70M | 1.69B | 1.41B |
Year over Year Growth Est. | -15.74% | -14.07% | -16.41% | 3.25% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.75 | 0.35 | 2.63 | 3.80 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.90 | 0.62 | 3.06 | 4.14 |
Low Estimate | 0.60 | 0.07 | 2.20 | 3.45 |
Year ago EPS | 1.21 | 0.21 | 3.94 | 2.63 |
Year over Year Growth Est. | -38.02% | 66.67% | -33.25% | 44.30% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 2 | 2 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.75 | 0.35 | 2.63 | 3.80 |
7 Days Ago | 0.75 | 0.35 | 2.63 | 3.80 |
30 Days Ago | 1.26 | 0.89 | 3.64 | 4.77 |
60 Days Ago | 1.26 | 0.89 | 3.64 | 4.77 |
90 Days Ago | 1.33 | 0.92 | 3.78 | 5.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.75 | 0.35 | 2.63 | 3.80 |
Zacks Consensus Estimate | 0.75 | 0.35 | 2.63 | 3.80 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.01 | 0.52 | 0.21 | 1.21 | NA |
Estimate | 1.05 | 0.37 | -0.13 | 1.22 | NA |
Difference | -0.04 | 0.15 | 0.34 | -0.01 | 0.11 |
Surprise | -3.81% | 40.54% | 261.54% | -0.82% | 74.36% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more